Stock Taper Total Revenues: $224.7 million, up 2.9% on a core basis.
Food Safety Segment: Revenues of $165.6 million, with core growth of 4.1%.
Animal Safety Segment: Revenues of $59.1 million, core growth flat year-over-year.
Gross Margin: 47.5%, improved by 210 basis points sequentially; adjusted gross margin at 50.3%.
Adjusted EBITDA: $48.7 million, margin of 21.7%, up 470 basis points from Q1.
Adjusted Net Income: $22.6 million, or $0.10 per share, compared to $9.4 million and $0.04 in the prior quarter.
Free Cash Flow: $7.8 million, an improvement of $20.9 million from Q1.
Debt: Gross debt of $800 million, with $145.3 million in cash.
Transformation Focus: Emphasis on stabilizing core operations and improving profitability, with $20 million in expected annualized cost savings from recent restructuring.
Leadership Changes: New CFO Brian Rigsby and CCO Joe Friels, alongside other key hires, to enhance operational execution and sales culture.
Product Development: Positive progress on the integration of Petrifilm, with production testing and initial validation phases underway, on track for completion by November 2027.
Commercial Strategy: Shift towards solutions-based selling in food safety to enhance customer retention and expand product portfolio penetration.
Revenue Guidance: Raised to $845 million to $855 million for FY 2026.
Adjusted EBITDA Guidance: Approximately $175 million for the fiscal year.
Cautious Approach: Despite the positive Q2 performance, management remains conservative due to lingering macroeconomic challenges and the need for the new leadership team to settle in.
Market Headwinds: Ongoing macroeconomic challenges, including inflationary pressures and disruptions in food production, affecting customer volumes and overall market conditions.
Animal Safety Segment: Flat revenue growth and declining production animal herds in the U.S. could impact future performance, though a recovery is anticipated.
Sample Collection Product Line: Continues to face profitability challenges, with expectations for improvement in the second half of the fiscal year, but margins remain under pressure.
Inventory Management: Elevated inventory write-offs noted, with a multi-quarter process expected to normalize levels.
Leadership Impact: CEO Mike Nassif emphasized the importance of attracting experienced leaders to drive operational excellence and simplify processes.
Forecasting Changes: Transition from monthly to weekly forecasting meetings to enhance accuracy and accountability in revenue projections.
Customer Relationships: Customers are supportive and view Neogen as a vital partner in food safety, despite some frustrations with supply issues.
Growth Drivers: The growth in indicator testing and culture media was primarily volume-driven, with expectations for continued organic growth in these areas. Overall, Neogen's Q2 2026 results reflect a positive turnaround with strategic initiatives in place to enhance growth and profitability, despite facing significant market challenges. The management's cautious optimism and proactive measures signal a commitment to long-term improvement.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT